{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:17:10Z","timestamp":1784078230772,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.taap.2023.116610","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T02:55:20Z","timestamp":1687920920000},"page":"116610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["CYP2J deficiency leads to cardiac injury and presents dual regulatory effects on cardiac function in rats"],"prefix":"10.1016","volume":"473","author":[{"given":"Yanfang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.taap.2023.116610_bb0005","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/ijms19071916","article-title":"Regulation of CYP2J2 and EET levels in cardiac disease and diabetes","volume":"19","author":"Aliwarga","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.taap.2023.116610_bb0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/03602532.2012.754460","article-title":"Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy","volume":"45","author":"Alsaad","year":"2013","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.taap.2023.116610_bb0015","doi-asserted-by":"crossref","first-page":"9363569","DOI":"10.1155\/2021\/9363569","article-title":"Cardiac injury biomarkers and the risk of death in patients with COVID-19: a systematic review and meta-analysis","volume":"2021","author":"Alzahrani","year":"2021","journal-title":"Cardiol. Res. Pract."},{"issue":"1","key":"10.1016\/j.taap.2023.116610_bb0020","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1186\/s12889-022-13944-w","article-title":"Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review","volume":"22","author":"Badawy","year":"2022","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.taap.2023.116610_bb0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","article-title":"PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure","volume":"20","author":"Cant\u00f3","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.taap.2023.116610_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113763","article-title":"Investigation of the content differences of arachidonic acid metabolites in a mouse model of breast cancer by using LC-MS\/MS","volume":"194","author":"Chen","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.taap.2023.116610_bb0035","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/jcp.24939","article-title":"Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction","volume":"230","author":"Dai","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.taap.2023.116610_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160380","article-title":"Novel roles of epoxyeicosanoids in regulating cardiac mitochondria","volume":"11","author":"El-Sikhry","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.taap.2023.116610_bb0045","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.113.053389","article-title":"Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes","volume":"41","author":"Evangelista","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"22","key":"10.1016\/j.taap.2023.116610_bb0050","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart failure: JACC state-of-the-art review","volume":"75","author":"Ferreira","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.taap.2023.116610_bb0055","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/1535370218777972","article-title":"Dysfunctional Nav1.5 channels due to SCN5A mutations","volume":"243","author":"Han","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)."},{"issue":"3","key":"10.1016\/j.taap.2023.116610_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003273","article-title":"International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework","volume":"14","author":"James","year":"2021","journal-title":"Circ. Genom. Precis. Med."},{"issue":"7","key":"10.1016\/j.taap.2023.116610_bb0065","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/cells9071565","article-title":"Mitochondrial dysfunction and inflammaging in heart failure: novel roles of CYP-derived epoxylipids","volume":"9","author":"Keshavarz-Bahaghighat","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.taap.2023.116610_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107863","article-title":"The natriuretic peptide system in heart failure: diagnostic and therapeutic implications","volume":"227","author":"Kuwahara","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.taap.2023.116610_bb0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/FJC.0000000000000371","article-title":"CYP2J2 overexpression increases EETs and protects against HFD-induced atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"67","author":"Liu","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"Pt 2","key":"10.1016\/j.taap.2023.116610_bb0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1113\/jphysiol.2006.113985","article-title":"Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms","volume":"575","author":"Lu","year":"2006","journal-title":"J. Physiol."},{"issue":"11","key":"10.1016\/j.taap.2023.116610_bb0085","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/dmd.120.000114","article-title":"Generation and characterization of cytochrome P450 2J3\/10 CRISPR\/Cas9 knockout rat model","volume":"48","author":"Lu","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.taap.2023.116610_bb0090","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.taap.2023.116610_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-016-9530-2","article-title":"Mitochondrial dynamics and cell death in heart failure","volume":"21","author":"Mar\u00edn-Garc\u00eda","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.taap.2023.116610_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"8","key":"10.1016\/j.taap.2023.116610_bb0105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1042\/CS20180728","article-title":"Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats","volume":"133","author":"Neck\u00e1\u0159","year":"2019","journal-title":"Clin. Sci."},{"issue":"2","key":"10.1016\/j.taap.2023.116610_bb0110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.taap.2023.116610_bb0115","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cvr\/cvn327","article-title":"Tnf-alpha reduces pgc-1alpha expression through nf-kappab and p38 mapk leading to increased glucose oxidation in a human cardiac cell model","volume":"81","author":"Palomer","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.taap.2023.116610_bb0120","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/FJC.0000000000001013","article-title":"Unraveling the role of 12- and 20- HETE in cardiac pathophysiology: G-protein-coupled receptors, pharmacological inhibitors, and transgenic approaches","volume":"77","author":"Pascale","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2023.116610_bb0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2008\/626430","article-title":"A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population","volume":"24","author":"Polonikov","year":"2008","journal-title":"Dis. Markers"},{"key":"10.1016\/j.taap.2023.116610_bb0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.gene.2015.10.052","article-title":"TNNI1, TNNI2 and TNNI3: evolution, regulation, and protein structure-function relationships","volume":"576","author":"Sheng","year":"2016","journal-title":"Gene."},{"issue":"1","key":"10.1016\/j.taap.2023.116610_bb0135","first-page":"233","article-title":"CYP-450 Epoxygenase derived epoxyeicosatrienoic acid contribute to reversal of heart failure in obesity-induced diabetic cardiomyopathy via PGC-1 \u03b1 activation","volume":"7","author":"Singh","year":"2018","journal-title":"Cardiovasc. Pharm. Open Access."},{"issue":"5\u20136","key":"10.1016\/j.taap.2023.116610_bb0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.vph.2013.02.004","article-title":"Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line","volume":"58","author":"Tse","year":"2013","journal-title":"Vasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2023.116610_bb0145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cyto.2012.04.029","article-title":"Upregulation of cytochrome P450 2J3\/11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway","volume":"60","author":"Wang","year":"2012","journal-title":"Cytokine."},{"issue":"5","key":"10.1016\/j.taap.2023.116610_bb0150","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acel.12507","article-title":"CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPK\u03b12 and enhancing nuclear translocation of Akt1","volume":"15","author":"Wang","year":"2016","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.taap.2023.116610_bb0155","article-title":"Association of CYP2J2 gene polymorphisms with ischemic stroke and stroke subtypes in Chinese population","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.taap.2023.116610_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/03602532.2013.806537","article-title":"Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance","volume":"45","author":"Xu","year":"2013","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.taap.2023.116610_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121122","article-title":"Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs","volume":"310","author":"Zhang","year":"2022","journal-title":"Life Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23002491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23002491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:02:53Z","timestamp":1758574973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X23002491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":33,"alternative-id":["S0041008X23002491"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2023.116610","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP2J deficiency leads to cardiac injury and presents dual regulatory effects on cardiac function in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2023.116610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116610"}}